CA3052503C - Procedes pour traiter la grippe - Google Patents

Procedes pour traiter la grippe

Info

Publication number
CA3052503C
CA3052503C CA3052503A CA3052503A CA3052503C CA 3052503 C CA3052503 C CA 3052503C CA 3052503 A CA3052503 A CA 3052503A CA 3052503 A CA3052503 A CA 3052503A CA 3052503 C CA3052503 C CA 3052503C
Authority
CA
Canada
Prior art keywords
influenza
virus
pharmaceutically acceptable
acceptable salt
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3052503A
Other languages
English (en)
Other versions
CA3052503A1 (fr
Inventor
Gary Ewart
Carolyn Luscombe
Original Assignee
Biotron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotron Ltd filed Critical Biotron Ltd
Priority claimed from PCT/AU2018/050085 external-priority patent/WO2018145148A1/fr
Publication of CA3052503A1 publication Critical patent/CA3052503A1/fr
Application granted granted Critical
Publication of CA3052503C publication Critical patent/CA3052503C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne le traitement ou la prévention d'une infection par le virus de la grippe. En particulier, la présente invention concerne l'utilisation de N-carbamimidoyl-5-(1-méthyl-1H-pyrazol-4-yl)-2-naphtamide, ou d'un sel pharmaceutiquement acceptable de celui-ci, dans le traitement ou la prévention d'une infection par le virus de la grippe.
CA3052503A 2017-02-08 2018-02-07 Procedes pour traiter la grippe Active CA3052503C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017900385A AU2017900385A0 (en) 2017-02-08 Methods of treating influenza
AU2017900385 2017-02-08
PCT/AU2018/050085 WO2018145148A1 (fr) 2017-02-08 2018-02-07 Procédés pour traiter la grippe

Publications (2)

Publication Number Publication Date
CA3052503A1 CA3052503A1 (fr) 2018-08-16
CA3052503C true CA3052503C (fr) 2026-02-17

Family

ID=

Similar Documents

Publication Publication Date Title
AU2018218179B2 (en) Methods of treating influenza
Tarbet et al. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
Wang et al. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret)
WO2017223231A1 (fr) (s)-8-(benzhydryl)-6-isopropyl-3,5-dioxo-5,6,7,8,-tétrahydro-3 h-pyrazino-[1,2-b] pyridazin-yl-isobutyrate, agent antiviral destiné à être utilisé dans le traitement de la grippe
US20140121237A1 (en) Methods for Inhibiting Virus Replication
US10221152B2 (en) Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus
EP3934653B1 (fr) Azelastine destiné au traitement antiviral
CA3052503C (fr) Procedes pour traiter la grippe
CN110870864B (zh) 马来酸卡比沙明在制备抗流感病毒药物中的应用
CN118574614A (zh) 治疗sars-cov-2感染的方法
HK40017310B (en) Methods of treating influenza
HK40017310A (en) Methods of treating influenza
CN114377009A (zh) Sb216763在制备抗流感病毒药物中的应用
Pakvis Current trends of hemagglutinin and M2 protein inhibition for the treatment of influenza using antivirals
WO2019089734A1 (fr) Méthodes et compositions pour le traitement de la grippe
CN107898783A (zh) 1，3‑二羟基‑6‑苯并[c]色烯酮在制备抗流感病毒药物中的应用
TWI530284B (zh) 馬替麥考酚酯或其鹽類用於製備抗流感病毒之藥物的用途